Salmon Sean's Form 4 filing
Medtronic plcMDT · filed Feb 23, 2024
- Accession no.
- 0001613103-24-000008
- Filed
- Feb 23, 2024
- Trade date
- Feb 21, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $2.61M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Salmon SeanCIK 0001792380 | Officer (EVP & President Cardiovascular) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Ordinary Shares | MOption exerciseAcquired | +1,594 | $62.76 | +$100,039.44 | 49,833 | Direct | |
| Feb 21, 2024 | Ordinary Shares | MOption exerciseAcquired | +13,066 | $62.76 | +$820,022.16 | 62,949 | Direct | |
| Feb 21, 2024 | Ordinary Shares | MOption exerciseAcquired | +16,035 | $74.84 | +$1,200,059.4 | 78,984 | Direct | |
| Feb 21, 2024 | Ordinary Shares | SSaleDisposed | −1,594 | $85.06 | −$135,585.64 | 77,390 | Direct | |
| Feb 21, 2024 | Ordinary Shares | SSaleDisposed | −13,066 | $85.15F2 | −$1,112,569.9 | 64,324 | Direct | |
| Feb 21, 2024 | Ordinary Shares | SSaleDisposed | −16,035 | $85.12F3 | −$1,364,899.2 | 48,289 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 21, 2024 | Ordinary Shares | MOption exerciseDisposed | −1,594 | $0.00 | $0 | 13,066 | Direct | |
| Feb 21, 2024 | Ordinary Shares | MOption exerciseDisposed | −13,066 | $0.00 | $0 | 0 | Direct | |
| Feb 21, 2024 | Ordinary Shares | MOption exerciseDisposed | −16,035 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.15 to $85.18. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported is a weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $85.12 to $85.14. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder upon request.
Referenced by the price of 1 transaction in Table I.